| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cost Effectiveness of Eplerenone in Patients with Chronic Heart Failure
|
Ademi, Zanfina
|
|
2014
|
14 |
3 |
p. 209-216
|
artikel
|
| 2 |
Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
|
Dézsi, Csaba András
|
|
2013
|
14 |
3 |
p. 167-173
|
artikel
|
| 3 |
Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers
|
Andersson, Tommy
|
|
2014
|
14 |
3 |
p. 217-227
|
artikel
|
| 4 |
Erratum to: Antihypertensive Efficacy of Triple Combination Perindopril/Indapamide Plus Amlodipine in High-Risk Hypertensives: Results of the PIANIST Study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients)
|
Tóth, Kálmán
|
|
2014
|
14 |
3 |
p. 239
|
artikel
|
| 5 |
Erratum to: Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice
|
Gonzalez-Quesada, Carlos J.
|
|
2014
|
14 |
3 |
p. 237
|
artikel
|
| 6 |
Heart Rate Reduction with Ivabradine in Patients with Acute Decompensated Systolic Heart Failure
|
Sargento, Luis
|
|
2014
|
14 |
3 |
p. 229-235
|
artikel
|
| 7 |
Meta-Analysis of the Cardiovascular Outcomes with Dipeptidyl Peptidase 4 Inhibitors: Validation of the Current FDA Mandate
|
Agarwal, Shikhar
|
|
2014
|
14 |
3 |
p. 191-207
|
artikel
|
| 8 |
New Oral Anticoagulants in Practice: Pharmacological and Practical Considerations
|
Wang, Yishen
|
|
2014
|
14 |
3 |
p. 175-189
|
artikel
|
| 9 |
Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
|
Fisk, Marie
|
|
2014
|
14 |
3 |
p. 155-165
|
artikel
|
Tijdschrift beschrijving